By Jonathan Weiss | Tue, 08/13/2013 - 12:07
By looking at tens of thousands of women over decades, researchers have found that regularly consuming fish heavy in omega-3 fatty acids can reduce the incidence of rheumatoid arthritis significantly.
By Jonathan Weiss | Mon, 08/12/2013 - 20:22
Tivicay is a new integrase inhibitor made by GlaxoSmithKline which was shown to be slightly better than Gilead's Atripla in reducing viral load in HIV infected patients after 48 weeks.
By Jonathan Weiss | Mon, 08/12/2013 - 19:31
An experimental drug from Bristol-Meyers Squibb and Albany Molecular Research, code-named BMS-820836, was shown to have no more effectiveness in treating untreatable depression compared to drugs currently on the market.
By Jonathan Weiss | Mon, 08/12/2013 - 15:01
Using powerful genetic tools and a large pool of participants, researchers have found one genetic mutation common among five mental disorders.
By Jonathan Weiss | Mon, 08/12/2013 - 11:36
Michigan doctor Farid Fata falsely billed $35 million to Medicare after treating patients with chemotherapy even if they didn't have cancer.
By Jonathan Weiss | Mon, 08/12/2013 - 09:07
Weeks after GlaxoSmithKline had four executives in China put in jail, Sanofi is being investigated for over a quarter-million dollars in bribes.
By Jonathan Weiss | Sat, 08/10/2013 - 10:30
Because of the significant cost in reviewing drug approval applications, the FDA is now charging generics makers more, but not that much more compared to drug developers who make brand name drugs.
By Jonathan Weiss | Fri, 08/09/2013 - 13:12
Idan Zablocki was diagnosed with a rare genetic immune disorder that leaves him unable to fight off simple infections.
By Jonathan Weiss | Fri, 08/09/2013 - 11:00
As the Indian government revokes even more drug patents, such as those on Allergan's eye drugs, it sets a dangerous precedent for the lack of protection afforded to drug developers.
By Jonathan Weiss | Wed, 08/07/2013 - 17:04
In people with high blood sugar levels, researchers found markedly high chances of developing dementia.
By Jonathan Weiss | Wed, 08/07/2013 - 16:23
Nearly one-third of young American women practice the withdrawal method to prevent pregnancy, yet over 20 percent of them get pregnant anyway.
By Jonathan Weiss | Wed, 08/07/2013 - 11:43
Vaxart hopes to introduce a wide range of pill-based vaccines for diseases such as HPV and even the seasonal flu.
By Jonathan Weiss | Wed, 08/07/2013 - 10:35
Tolvaptan, which is already approved by the FDA for low blood sodium, has received a vote of no confidence from an advisory panel to the FDA.